Table 1 Baseline clinical and biochemical characteristics (mITT population)
From: A randomized trial of Plasma-Lyte A and 0.9 % sodium chloride in acute pediatric gastroenteritis
Plasma-Lyte A | 0.9 % NaCl | ||
|---|---|---|---|
n = 39 | n = 38 | ||
Age*, months, mean | 45.9 | 34.2 | |
Age group, n (%) | ≥6 months to ≤2 years | 8 (21) | 20 (53) |
>2 to ≤5 years | 21 (54) | 11 (29) | |
>5 to <11 years | 10 (26) | 7 (18) | |
Weight*, kg | 15.8 ± 5.18 | 13.5 ± 6.80 | |
Vomiting episodes | 8.9 ± 8.53 | 6.1 ± 5.92 | |
Diarrhea episodes | 4.8 ± 4.77 | 6.8 ± 6.77 | |
Capillary refill time*, seconds | 3.3 ± 0.50 | 2.8 ± 0.26 | |
Bicarbonate, mEq/L | 16.9 ± 3.51 | 17.8 ± 2.82 | |
Sodium, mEq/L | 137.0 ± 4.07 | 136.9 ± 2.93 | |
Potassium, mEq/L | 4.4 ± 0.80 | 4.2 ± 0.67 | |
Chloride, mEq/L | 103.0 ± 4.74 | 103.5 ± 4.19 | |
BUN, mg/dL | 16.5 ± 7.17 | 14.6 ± 6.33 | |
Creatinine*, mg/dL | 0.43 ± 0.13 | 0.37 ± 0.10 | |
Glucose, mg/dL | 70.3 ± 21.26 | 74.4 ± 21.62 | |
Gorelick dehydration scale, median (IQR) | 5 (5–6) | 5 (5–6) | |
Ondansetron | 36 (92) | 29 (76) | |
All analgesicsa | 25 (64) | 23 (61) | |